Clinical Trials Browser

Phase NA × Neoplasms × Raloxifene Hydrochloride × Clear all

NCT04926545 2024-07-30

XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)

Phase NA Completed

Diarrhea, Neoplasms